Health Information Technology in the Nursing Home

Status Completed

Clinical Trial Summary

The magnitude and intensity of medication use among our nation's 1.6 million nursing home residents matches or exceeds that of hospitalized patients. The residents of nursing homes are among the most frail patients in the population; the challenges of using medications in this setting are great, not only because of the physiologic declines and pharmacologic changes that occur with aging, but also because of the special clinical and social circumstances that often characterize nursing home care. In our previous research, we have determined that medication errors resulting in adverse drug events occur most often at the ordering and monitoring stages of pharmaceutical care. Clinical decision-support systems are clinical consultation systems that combine individual patient information with population statistics and scientific evidence to offer real-time information to health care providers. These systems have been found to improve the quality of medication prescribing in the hospital setting. In this study, we intend to determine the extent to which a computer-based clinical decision-support system (accompanying computerized provider order-entry) can improve the quality of medication ordering and monitoring for residents in the long-term care setting through a randomized trial. We will track the costs associated with this system and the system's impact on the productivity of providers. We will also assess the culture of U.S. nursing homes and the organization of the nursing home setting with respect to readiness to incorporate computerized provider order-entry with computer-based clinical decision support. Our project addresses specific areas that are of particular interest to AHRQ with special relevance to the delivery of high-quality care to a priority population--the frail elderly patient population residing in nursing homes. The project will assess the economic implications of health information technology in the nursing home environment that will be of interest to key stakeholders, including physicians, pharmacists, nurses, payers, policymakers, the nursing home industry, and pharmaceutical vendors to long-term care institutions.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00599209
Study type	Interventional
Source	University of Massachusetts, Worcester
Contact
Status	Completed
Phase	N/A
Start date	September 2004
Completion date	September 2008

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT06043895` - EpiFaith CV for Central Venous Catheterization	N/A
Not yet recruiting	`NCT05958108` - Effectivenness and Implementation of an Intervention to Improve Primary Care Patient Safety	Phase 3
Recruiting	`NCT02574104` - Generalizing TESTPILOT to New Single Family Room NICUs	N/A
Completed	`NCT04576299` - Health Care Workers' Perception of Patient Safety During COVID-19 Pandemic
Completed	`NCT03663491` - Necessity of Transnasal Gastroscopy in Routine Diagnostics - a Patient Centered Requirement Analysis	N/A
Completed	`NCT00212927` - Continuity of Care and Outcomes After Discharge From Hospital	N/A
Not yet recruiting	`NCT05062434` - An Intervention to Impact Cardiovascular Implantable Electronic Device Lead Models Implanted in Veterans	N/A
Recruiting	`NCT06089239` - De-Implementing Fall Prevention Alarms in Hospitals	N/A
Recruiting	`NCT04861025` - Siderails as a Measure of Physical Restraint. GERBAR Trial
Completed	`NCT04990986` - Co-Development and Evaluation of a Complex Intervention to Increase Medication Safety in Nursing Homes	N/A
Recruiting	`NCT02955836` - Effectiveness of Monitoring Information System of Nursing Related Patient Safety and Quality Indicators	N/A
Completed	`NCT01246544` - Helsinki Declaration on Patient Safety	N/A
Recruiting	`NCT05530187` - ePRO-based Model of Care to Manage and Monitoring Symptoms of Cancer Patients Treated With Immune Checkpoint Inhibitors	N/A
Recruiting	`NCT04176094` - Intensive Care Unit Resident Scheduling Trial	N/A
Completed	`NCT05794490` - Learning From Excellence in a Hospital Unit
Recruiting	`NCT06269250` - Acceptance and Perceived Benefits of Digitalization by Medical Assistants
Recruiting	`NCT03105713` - Development and Implementation of Patient Safety Checklists Before, During and After In-hospital Surgery	N/A
Completed	`NCT04184570` - Audit of International Intraoperative Hemotherapy and Blood Loss Documentation
Recruiting	`NCT04897087` - Openness and Learning Joint Commission: Using Patient Experience for Improvement Following a Patient Safety Event
Active, not recruiting	`NCT06259812` - Machine Learning Prediction of Parameters of Early Warning Scores in Intensive Care Units

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.